The present invention relates to substituted dimethylcyclobutyl compounds of general formula I, a process for their preparation, medicaments comprising said substituted dimethylcyclobutyl compounds as well as the use of said substituted dimethylcyclobutyl compounds for the preparation of medicaments, which are particularly suitable for the prophylaxis and/or treatment of disorders or diseases that are at least partially mediated via sigma receptors.
本发明涉及通式I的取代二
甲基环丁基化合物,其制备方法,包含所述取代二
甲基环丁基化合物的药物以及使用所述取代二
甲基环丁基化合物制备药物,特别适用于预防和/或治疗至少部分通过sigma受体介导的疾病或疾病的药物。